DUBLIN--(BUSINESS WIRE)--ICON Medical Imaging, a division of ICON Plc (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the enhancement of its ICOSpeedRead™ system to incorporate RECIST 1.1 evaluation criteria.
